"Approval Date","Drug Name","Submission","Active Ingredients","Company","Submission Classification *","Submission Status"
"06/01/2022","TOPROL-XLNDA   #019962","SUPPL-49","METOPROLOL SUCCINATE","TOPROL","Labeling","Approval"
"06/01/2022","DYANAVEL XRNDA   #208147","SUPPL-12","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"06/01/2022","DYANAVEL XR 10NDA   #210526","SUPPL-1","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"06/01/2022","DYANAVEL XR 15NDA   #210526","SUPPL-1","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"06/01/2022","DYANAVEL XR 20NDA   #210526","SUPPL-1","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"06/01/2022","DYANAVEL XR 5NDA   #210526","SUPPL-1","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TRIS PHARMA INC","Labeling","Approval"
"06/01/2022","NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #211360","ORIG-1","NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE","AUROBINDO PHARMA","","Approval"
"06/01/2022","ACCRUFERNDA   #212320","SUPPL-13","FERRIC MALTOL","SHIELD TX","Labeling","Approval"
"06/01/2022","BRIVARACETAMANDA  #214831","ORIG-1","BRIVARACETAM","ANNORA PHARMA","","Tentative Approval"
"06/02/2022","CREONBLA   #020725","SUPPL-28","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","ABBVIE","","Approval"
"06/02/2022","BELRAPZONDA   #205580","SUPPL-12","BENDAMUSTINE HYDROCHLORIDE","EAGLE PHARMS","Labeling","Approval"
"06/02/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #212756","ORIG-1","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","AVEVA","","Approval"
"06/02/2022","NOREPINEPHRINE BITARTRATE IN 5% DEXTROSENDA   #214313","SUPPL-1","NOREPINEPHRINE BITARTRATE","BAXTER HLTHCARE CORP","Manufacturing (CMC)","Approval"
"06/02/2022","NOREPINEPHRINE BITARTRATE IN 5% DEXTROSENDA   #214313","SUPPL-2","NOREPINEPHRINE BITARTRATE","BAXTER HLTHCARE CORP","Manufacturing (CMC)","Approval"
"06/02/2022","TIOPRONINANDA  #216198","ORIG-1","TIOPRONIN","PAR PHARM INC","","Approval"
"06/02/2022","TESTOSTERONE CYPIONATENDA   #216318","ORIG-1","TESTOSTERONE CYPIONATE","SLAYBACK PHARMA LLC","Type 5 - New Formulation or New Manufacturer","Approval"
"06/03/2022","KETALARNDA   #016812","SUPPL-51","KETAMINE HYDROCHLORIDE","PAR STERILE PRODUCTS","Labeling","Approval"
"06/03/2022","ACETAMINOPHENNDA   #206968","ORIG-1","ACETAMINOPHEN","HIKMA","Type 5 - New Formulation or New Manufacturer","Approval"
"06/03/2022","MESALAMINEANDA  #207271","SUPPL-1","MESALAMINE","MYLAN PHARMS","Labeling","Approval"
"06/03/2022","MESALAMINEANDA  #207271","SUPPL-3","MESALAMINE","MYLAN PHARMS","Labeling","Approval"
"06/03/2022","MESALAMINEANDA  #208954","SUPPL-2","MESALAMINE","ZYDUS PHARMS","Labeling","Approval"
"06/03/2022","MESALAMINEANDA  #214242","SUPPL-1","MESALAMINE","ALKEM LABS LTD","Labeling","Approval"
"06/03/2022","ADAPALENE AND BENZOYL PEROXIDEANDA  #214553","ORIG-1","ADAPALENE; BENZOYL PEROXIDE","ZYDUS PHARMS","","Approval"
"06/03/2022","PIMAVANSERINANDA  #214925","ORIG-1","PIMAVANSERIN","MSN LABORATORIES PRIVATE LTD","","Tentative Approval"
"06/03/2022","FAMOTIDINEANDA  #216441","ORIG-1","FAMOTIDINE","ZYDUS PHARMS","","Approval"
"06/03/2022","TRODELVYBLA   #761115","SUPPL-23","SACITUZUMAB GOVITECAN-HZIY","IMMUNOMEDICS INC","","Approval"
"06/03/2022","RIABNIBLA   #761140","SUPPL-1","RITUXIMAB-ARRX","AMGEN INC","","Approval"
"06/06/2022","CELLCEPTNDA   #050722","SUPPL-49","MYCOPHENOLATE MOFETIL","ROCHE PALO","Efficacy","Approval"
"06/06/2022","CELLCEPTNDA   #050722","SUPPL-51","MYCOPHENOLATE MOFETIL","ROCHE PALO","Efficacy","Approval"
"06/06/2022","CELLCEPTNDA   #050723","SUPPL-49","MYCOPHENOLATE MOFETIL","ROCHE PALO","Efficacy","Approval"
"06/06/2022","CELLCEPTNDA   #050723","SUPPL-51","MYCOPHENOLATE MOFETIL","ROCHE PALO","Efficacy","Approval"
"06/06/2022","CELLCEPTNDA   #050758","SUPPL-47","MYCOPHENOLATE MOFETIL HYDROCHLORIDE","ROCHE PALO","Efficacy","Approval"
"06/06/2022","CELLCEPTNDA   #050758","SUPPL-49","MYCOPHENOLATE MOFETIL HYDROCHLORIDE","ROCHE PALO","Efficacy","Approval"
"06/06/2022","CELLCEPTNDA   #050759","SUPPL-54","MYCOPHENOLATE MOFETIL","ROCHE PALO","Efficacy","Approval"
"06/06/2022","CELLCEPTNDA   #050759","SUPPL-56","MYCOPHENOLATE MOFETIL","ROCHE PALO","Efficacy","Approval"
"06/06/2022","HYDROCHLOROTHIAZIDEANDA  #075640","SUPPL-23","HYDROCHLOROTHIAZIDE","MYLAN","Labeling","Approval"
"06/06/2022","HYDROCHLOROTHIAZIDEANDA  #075907","SUPPL-15","HYDROCHLOROTHIAZIDE","PRINSTON INC","Labeling","Approval"
"06/06/2022","BUPROPION HYDROCHLORIDEANDA  #075914","SUPPL-31","BUPROPION HYDROCHLORIDE","IMPAX LABS","Labeling","Approval"
"06/06/2022","LUTATHERANDA   #208700","SUPPL-20","LUTETIUM LU 177 DOTATATE","AAA USA INC","Labeling","Approval"
"06/06/2022","VALGANCICLOVIR HYDROCHLORIDEANDA  #209672","SUPPL-3","VALGANCICLOVIR HYDROCHLORIDE","CIPLA","Labeling","Approval"
"06/06/2022","VALGANCICLOVIR HYDROCHLORIDEANDA  #209672","SUPPL-5","VALGANCICLOVIR HYDROCHLORIDE","CIPLA","Labeling","Approval"
"06/06/2022","VORICONAZOLEANDA  #211099","SUPPL-1","VORICONAZOLE","GLAND PHARMA LTD","Labeling","Approval"
"06/06/2022","VORICONAZOLEANDA  #211099","SUPPL-2","VORICONAZOLE","GLAND PHARMA LTD","Labeling","Approval"
"06/06/2022","VORICONAZOLEANDA  #211099","SUPPL-4","VORICONAZOLE","GLAND PHARMA LTD","Labeling","Approval"
"06/06/2022","VORICONAZOLEANDA  #211099","SUPPL-7","VORICONAZOLE","GLAND PHARMA LTD","Labeling","Approval"
"06/06/2022","VORICONAZOLEANDA  #211099","SUPPL-8","VORICONAZOLE","GLAND PHARMA LTD","Labeling","Approval"
"06/06/2022","LEUPROLIDE ACETATEANDA  #212963","ORIG-1","LEUPROLIDE ACETATE","EUGIA PHARMA","","Approval"
"06/06/2022","POTASSIUM CHLORIDEANDA  #213062","ORIG-1","POTASSIUM CHLORIDE","WES PHARMA INC","","Approval"
"06/06/2022","LEQVIONDA   #214012","SUPPL-2","INCLISIRAN SODIUM","NOVARTIS","Labeling","Approval"
"06/06/2022","GANIRELIX ACETATEANDA  #214996","ORIG-1","GANIRELIX ACETATE","MEITHEAL","","Approval"
"06/06/2022","AMITRIPTYLINE HYDROCHLORIDEANDA  #216243","ORIG-1","AMITRIPTYLINE HYDROCHLORIDE","LEADING","","Approval"
"06/06/2022","HEMLIBRABLA   #761083","SUPPL-15","EMICIZUMAB","GENENTECH INC","","Approval"
"06/07/2022","LANTUSBLA   #021081","SUPPL-76","INSULIN GLARGINE RECOMBINANT","SANOFI AVENTIS US","","Approval"
"06/07/2022","LANTUS SOLOSTARBLA   #021081","SUPPL-76","INSULIN GLARGINE RECOMBINANT","SANOFI AVENTIS US","","Approval"
"06/07/2022","FINASTERIDEANDA  #076511","SUPPL-24","FINASTERIDE","TEVA","Labeling","Approval"
"06/07/2022","FINASTERIDEANDA  #076511","SUPPL-28","FINASTERIDE","TEVA","Labeling","Approval"
"06/07/2022","OFLOXACINANDA  #076848","SUPPL-1","OFLOXACIN","SANDOZ","Labeling","Approval"
"06/07/2022","NADOLOLANDA  #201893","SUPPL-3","NADOLOL","AUROBINDO PHARMA","Manufacturing (CMC)","Approval"
"06/07/2022","LENALIDOMIDEANDA  #209348","SUPPL-2","LENALIDOMIDE","DR REDDYS","Labeling","Approval"
"06/07/2022","BRIVARACETAMANDA  #214922","ORIG-1","BRIVARACETAM","MSN LABS PVT LTD","","Tentative Approval"
"06/07/2022","NAPROXENANDA  #215776","ORIG-1","NAPROXEN","HETERO LABS LTD III","","Approval"
"06/07/2022","SORAFENIB TOSYLATEANDA  #216073","ORIG-1","SORAFENIB TOSYLATE","DR REDDYS","","Approval"
"06/07/2022","IVACAFTORANDA  #216074","ORIG-1","IVACAFTOR","LUPIN LTD","","Tentative Approval"
"06/07/2022","DUPIXENTBLA   #761055","SUPPL-42","DUPILUMAB","REGENERON PHARMACEUTICALS","","Approval"
"06/08/2022","ESCITALOPRAM OXALATEANDA  #202280","SUPPL-8","ESCITALOPRAM OXALATE","JUBILANT GENERICS","Labeling","Approval"
"06/08/2022","ESCITALOPRAM OXALATEANDA  #202280","SUPPL-13","ESCITALOPRAM OXALATE","JUBILANT GENERICS","Labeling","Approval"
"06/08/2022","ESCITALOPRAM OXALATEANDA  #202280","SUPPL-19","ESCITALOPRAM OXALATE","JUBILANT GENERICS","Labeling","Approval"
"06/08/2022","NEURACEQNDA   #204677","SUPPL-21","FLORBETABEN F-18","LIFE MOLECULAR","Manufacturing (CMC)","Approval"
"06/08/2022","NEOSTIGMINE METHYLSULFATEANDA  #207042","SUPPL-9","NEOSTIGMINE METHYLSULFATE","EUROHLTH INTL SARL","Labeling","Approval"
"06/08/2022","NEOSTIGMINE METHYLSULFATEANDA  #209135","SUPPL-2","NEOSTIGMINE METHYLSULFATE","DR REDDYS","Labeling","Approval"
"06/08/2022","MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4ANDA  #215371","ORIG-1","MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE","FRESENIUS KABI USA","","Approval"
"06/08/2022","GUANFACINE HYDROCHLORIDEANDA  #216399","ORIG-1","GUANFACINE HYDROCHLORIDE","TWI PHARMS","","Approval"
"06/09/2022","CEFUROXIME AXETILANDA  #065069","SUPPL-17","CEFUROXIME AXETIL","APOTEX","Labeling","Approval"
"06/09/2022","FLUCONAZOLEANDA  #076351","SUPPL-15","FLUCONAZOLE","MYLAN","Labeling","Approval"
"06/09/2022","FLUCONAZOLEANDA  #076351","SUPPL-16","FLUCONAZOLE","MYLAN","Labeling","Approval"
"06/09/2022","PANTOPRAZOLE SODIUMANDA  #078281","SUPPL-32","PANTOPRAZOLE SODIUM","LANNETT CO INC","Labeling","Approval"
"06/09/2022","EPOPROSTENOL SODIUMANDA  #078396","SUPPL-21","EPOPROSTENOL SODIUM","TEVA PHARMS USA","Labeling","Approval"
"06/09/2022","EPOPROSTENOL SODIUMANDA  #078396","SUPPL-22","EPOPROSTENOL SODIUM","TEVA PHARMS USA","Labeling","Approval"
"06/09/2022","EPOPROSTENOL SODIUMANDA  #078396","SUPPL-23","EPOPROSTENOL SODIUM","TEVA PHARMS USA","Labeling","Approval"
"06/09/2022","XIAFLEXBLA   #125338","SUPPL-127","COLLAGENASE CLOSTRIDIUM HISTOLYTICUM","AUXILIUM PHARMS","","Approval"
"06/09/2022","PANTOPRAZOLE SODIUMANDA  #202038","SUPPL-22","PANTOPRAZOLE SODIUM","AUROBINDO PHARMA LTD","Labeling","Approval"
"06/09/2022","PANTOPRAZOLE SODIUMANDA  #202038","SUPPL-23","PANTOPRAZOLE SODIUM","AUROBINDO PHARMA LTD","Labeling","Approval"
"06/09/2022","FLUCONAZOLEANDA  #208963","SUPPL-10","FLUCONAZOLE","ZYDUS PHARMS","Labeling","Approval"
"06/09/2022","FLUCONAZOLEANDA  #208963","SUPPL-11","FLUCONAZOLE","ZYDUS PHARMS","Labeling","Approval"
"06/09/2022","BRIMONIDINE TARTRATEANDA  #209158","SUPPL-1","BRIMONIDINE TARTRATE","PADAGIS ISRAEL","Manufacturing (CMC)","Approval"
"06/09/2022","PANTOPRAZOLE SODIUMANDA  #211368","SUPPL-3","PANTOPRAZOLE SODIUM","INGENUS PHARMS LLC","Labeling","Approval"
"06/09/2022","PANTOPRAZOLE SODIUMANDA  #211368","SUPPL-4","PANTOPRAZOLE SODIUM","INGENUS PHARMS LLC","Labeling","Approval"
"06/09/2022","METFORMIN HYDROCHLORIDEANDA  #212681","ORIG-1","METFORMIN HYDROCHLORIDE","PRINSTON INC","","Approval"
"06/09/2022","URSODIOLANDA  #213504","SUPPL-1","URSODIOL","STRIDES PHARMA","Labeling","Approval"
"06/09/2022","NALOXONE HYDROCHLORIDEANDA  #213843","ORIG-1","NALOXONE HYDROCHLORIDE","MYLAN LABS LTD","","Approval"
"06/09/2022","IBUPROFENANDA  #214071","ORIG-1","IBUPROFEN","STRIDES PHARMA","","Approval"
"06/09/2022","BRIVARACETAMANDA  #214748","ORIG-1","BRIVARACETAM","SUNSHINE","","Approval"
"06/09/2022","LIDOCAINE HYDROCHLORIDEANDA  #215132","ORIG-1","LIDOCAINE HYDROCHLORIDE","AFAXYS","","Approval"
"06/09/2022","TOPIRAMATEANDA  #215663","ORIG-1","TOPIRAMATE","AJANTA PHARMA LTD","","Tentative Approval"
"06/09/2022","DASATINIBANDA  #216261","ORIG-1","DASATINIB","ALEMBIC PHARMS LTD","","Tentative Approval"
"06/09/2022","BYOOVIZBLA   #761202","SUPPL-4","RANIBIZUMAB-NUNA","SAMSUNG BIOEPIS CO LTD","","Approval"
"06/10/2022","VIRAMUNENDA   #020636","SUPPL-52","NEVIRAPINE","BOEHRINGER INGELHEIM","Labeling","Approval"
"06/10/2022","VIRAMUNENDA   #020933","SUPPL-43","NEVIRAPINE","BOEHRINGER INGELHEIM","Labeling","Approval"
"06/10/2022","BYETTANDA   #021773","SUPPL-46","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling","Approval"
"06/10/2022","BYETTANDA   #021773","SUPPL-47","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling","Approval"
"06/10/2022","BYDUREONNDA   #022200","SUPPL-33","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling","Approval"
"06/10/2022","BYDUREON PENNDA   #022200","SUPPL-33","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling","Approval"
"06/10/2022","VICTOZANDA   #022341","SUPPL-37","LIRAGLUTIDE RECOMBINANT","NOVO NORDISK INC","Labeling","Approval"
"06/10/2022","VICTOZANDA   #022341","SUPPL-38","LIRAGLUTIDE RECOMBINANT","NOVO NORDISK INC","Labeling","Approval"
"06/10/2022","ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEANDA  #076972","SUPPL-9","ONDANSETRON HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"06/10/2022","ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEANDA  #076972","SUPPL-10","ONDANSETRON HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"06/10/2022","ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEANDA  #076972","SUPPL-17","ONDANSETRON HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"06/10/2022","ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEANDA  #076972","SUPPL-18","ONDANSETRON HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"06/10/2022","ONDANSETRON HYDROCHLORIDEANDA  #076974","SUPPL-8","ONDANSETRON HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"06/10/2022","ONDANSETRON HYDROCHLORIDEANDA  #076974","SUPPL-9","ONDANSETRON HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"06/10/2022","ONDANSETRON HYDROCHLORIDEANDA  #076974","SUPPL-16","ONDANSETRON HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"06/10/2022","ONDANSETRON HYDROCHLORIDEANDA  #076974","SUPPL-17","ONDANSETRON HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"06/10/2022","LAMOTRIGINEANDA  #077633","SUPPL-35","LAMOTRIGINE","ZYDUS PHARMS USA","Labeling","Approval"
"06/10/2022","LAMOTRIGINEANDA  #077633","SUPPL-37","LAMOTRIGINE","ZYDUS PHARMS USA","Labeling","Approval"
"06/10/2022","LAMOTRIGINEANDA  #078009","SUPPL-28","LAMOTRIGINE","ZYDUS PHARMS USA INC","Labeling","Approval"
"06/10/2022","LAMOTRIGINEANDA  #078009","SUPPL-29","LAMOTRIGINE","ZYDUS PHARMS USA INC","Labeling","Approval"
"06/10/2022","TRULICITYBLA   #125469","SUPPL-46","DULAGLUTIDE","ELI LILLY AND CO","","Approval"
"06/10/2022","TRULICITYBLA   #125469","SUPPL-52","DULAGLUTIDE","ELI LILLY AND CO","","Approval"
"06/10/2022","VIRAMUNE XRNDA   #201152","SUPPL-14","NEVIRAPINE","BOEHRINGER INGELHEIM","Labeling","Approval"
"06/10/2022","IRBESARTAN AND HYDROCHLOROTHIAZIDEANDA  #201524","SUPPL-17","HYDROCHLOROTHIAZIDE; IRBESARTAN","LUPIN LTD","Labeling","Approval"
"06/10/2022","IRBESARTAN AND HYDROCHLOROTHIAZIDEANDA  #201524","SUPPL-18","HYDROCHLOROTHIAZIDE; IRBESARTAN","LUPIN LTD","Labeling","Approval"
"06/10/2022","IRBESARTAN AND HYDROCHLOROTHIAZIDEANDA  #201524","SUPPL-19","HYDROCHLOROTHIAZIDE; IRBESARTAN","LUPIN LTD","Labeling","Approval"
"06/10/2022","IRBESARTAN AND HYDROCHLOROTHIAZIDEANDA  #201524","SUPPL-20","HYDROCHLOROTHIAZIDE; IRBESARTAN","LUPIN LTD","Labeling","Approval"
"06/10/2022","IRBESARTAN; HYDROCHLOROTHIAZIDEANDA  #201524","SUPPL-17","IRBESARTAN; HYDROCHLOROTHIAZIDE","LUPIN LTD","Labeling","Approval"
"06/10/2022","IRBESARTAN; HYDROCHLOROTHIAZIDEANDA  #201524","SUPPL-18","IRBESARTAN; HYDROCHLOROTHIAZIDE","LUPIN LTD","Labeling","Approval"
"06/10/2022","IRBESARTAN; HYDROCHLOROTHIAZIDEANDA  #201524","SUPPL-19","IRBESARTAN; HYDROCHLOROTHIAZIDE","LUPIN LTD","Labeling","Approval"
"06/10/2022","IRBESARTAN; HYDROCHLOROTHIAZIDEANDA  #201524","SUPPL-20","IRBESARTAN; HYDROCHLOROTHIAZIDE","LUPIN LTD","Labeling","Approval"
"06/10/2022","NILOTINIB HYDROCHLORIDEANDA  #203640","ORIG-1","NILOTINIB HYDROCHLORIDE","APOTEX INC","","Tentative Approval"
"06/10/2022","SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERANDA  #208122","SUPPL-11","SODIUM CHLORIDE","FRESENIUS KABI USA","Manufacturing (CMC)","Approval"
"06/10/2022","ADLYXINBLA   #208471","SUPPL-5","LIXISENATIDE","SANOFI-AVENTIS US","","Approval"
"06/10/2022","XULTOPHY 100/3.6BLA   #208583","SUPPL-18","INSULIN DEGLUDEC; LIRAGLUTIDE","NOVO","","Approval"
"06/10/2022","XULTOPHY 100/3.6BLA   #208583","SUPPL-19","INSULIN DEGLUDEC; LIRAGLUTIDE","NOVO","","Approval"
"06/10/2022","SOLIQUA 100/33BLA   #208673","SUPPL-12","INSULIN GLARGINE; LIXISENATIDE","SANOFI-AVENTIS US","","Approval"
"06/10/2022","PEMETREXED DITROMETHAMINENDA   #208746","ORIG-1","PEMETREXED DITROMETHAMINE","HOSPIRA","Type 3 - New Dosage Form","Approval"
"06/10/2022","RUBRACANDA   #209115","SUPPL-11","RUCAPARIB CAMSYLATE","CLOVIS ONCOLOGY INC","Efficacy","Approval"
"06/10/2022","BYDUREON BCISENDA   #209210","SUPPL-21","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling","Approval"
"06/10/2022","TADALAFILANDA  #209654","SUPPL-21","TADALAFIL","AJANTA PHARMA LTD","Labeling","Approval"
"06/10/2022","MAYZENTNDA   #209884","SUPPL-10","SIPONIMOD FUMARIC ACID","NOVARTIS","Labeling","Approval"
"06/10/2022","TIZANIDINE HYDROCHLORIDEANDA  #212196","SUPPL-1","TIZANIDINE HYDROCHLORIDE","ALKEM LABS LTD","Labeling","Approval"
"06/10/2022","NALOXONE HYDROCHLORIDEANDA  #212300","ORIG-1","NALOXONE HYDROCHLORIDE","HIKMA","","Approval"
"06/10/2022","RYBELSUSNDA   #213051","SUPPL-11","SEMAGLUTIDE","NOVO","Labeling","Approval"
"06/10/2022","TIZANIDINE HYDROCHLORIDEANDA  #213223","SUPPL-3","TIZANIDINE HYDROCHLORIDE","ALEMBIC","Labeling","Approval"
"06/10/2022","TIZANIDINE HYDROCHLORIDEANDA  #213544","SUPPL-1","TIZANIDINE HYDROCHLORIDE","AUROBINDO PHARMA LTD","Labeling","Approval"
"06/10/2022","Nitrogen, NFNDA   #217499","ORIG-1","Nitrogen","ABSOLUTE AIR, LLC","","Approval"
"06/10/2022","OXYGEN, USPNDA   #217500","ORIG-1","OXYGEN","ABSOLUTE AIR, LLC","","Approval"
"06/13/2022","POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINERNDA   #019904","SUPPL-21","POTASSIUM CHLORIDE","BAXTER HLTHCARE","Labeling","Approval"
"06/13/2022","POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINERNDA   #019904","SUPPL-21","POTASSIUM CHLORIDE","BAXTER HLTHCARE","Labeling","Approval"
"06/13/2022","POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINERNDA   #019904","SUPPL-21","POTASSIUM CHLORIDE","BAXTER HLTHCARE","Labeling","Approval"
"06/13/2022","POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINERNDA   #019904","SUPPL-21","POTASSIUM CHLORIDE","BAXTER HLTHCARE","Labeling","Approval"
"06/13/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090279","SUPPL-12","BUPRENORPHINE HYDROCHLORIDE","RUBICON","Labeling","Approval"
"06/13/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091149","SUPPL-16","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","TEVA PHARMS USA","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #200265","SUPPL-15","VORICONAZOLE","SANDOZ INC","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #200265","SUPPL-16","VORICONAZOLE","SANDOZ INC","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #200265","SUPPL-17","VORICONAZOLE","SANDOZ INC","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #200265","SUPPL-18","VORICONAZOLE","SANDOZ INC","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #200265","SUPPL-19","VORICONAZOLE","SANDOZ INC","Labeling","Approval"
"06/13/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #201066","SUPPL-14","BUPRENORPHINE HYDROCHLORIDE","MYLAN PHARMS","Labeling","Approval"
"06/13/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #201760","SUPPL-20","BUPRENORPHINE HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"06/13/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #201760","SUPPL-24","BUPRENORPHINE HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #203503","SUPPL-5","VORICONAZOLE","GLENMARK PHARMS LTD","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #203503","SUPPL-6","VORICONAZOLE","GLENMARK PHARMS LTD","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #203503","SUPPL-7","VORICONAZOLE","GLENMARK PHARMS LTD","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #203503","SUPPL-8","VORICONAZOLE","GLENMARK PHARMS LTD","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #203503","SUPPL-9","VORICONAZOLE","GLENMARK PHARMS LTD","Labeling","Approval"
"06/13/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205601","SUPPL-6","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RHODES PHARMS","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #206181","SUPPL-22","VORICONAZOLE","AJANTA PHARMA LTD","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #206181","SUPPL-23","VORICONAZOLE","AJANTA PHARMA LTD","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #206747","SUPPL-9","VORICONAZOLE","CADILA","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #206747","SUPPL-10","VORICONAZOLE","CADILA","Labeling","Approval"
"06/13/2022","VORICONAZOLEANDA  #206747","SUPPL-12","VORICONAZOLE","CADILA","Labeling","Approval"
"06/13/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #207276","SUPPL-10","BUPRENORPHINE HYDROCHLORIDE","RHODES PHARMS","Labeling","Approval"
"06/13/2022","OLUMIANTNDA   #207924","SUPPL-7","BARICITINIB","ELI LILLY AND CO","Efficacy","Approval"
"06/13/2022","LUTATHERANDA   #208700","SUPPL-19","LUTETIUM LU 177 DOTATATE","AAA USA INC","Efficacy","Approval"
"06/13/2022","LUTATHERANDA   #208700","SUPPL-23","LUTETIUM LU 177 DOTATATE","AAA USA INC","Labeling","Approval"
"06/13/2022","PIRFENIDONEANDA  #212600","ORIG-1","PIRFENIDONE","SANDOZ INC","","Approval"
"06/13/2022","AMVUTTRANDA   #215515","ORIG-1","VUTRISIRAN SODIUM","ALNYLAM PHARMS INC","Type 1 - New Molecular Entity","Approval"
"06/13/2022","PROCHLORPERAZINE MALEATEANDA  #216202","ORIG-1","PROCHLORPERAZINE MALEATE","NOVITIUM PHARMA","","Approval"
"06/14/2022","DIFFERINNDA   #020380","SUPPL-21","ADAPALENE","GALDERMA LABS LP","Labeling","Approval"
"06/14/2022","GALANTAMINE HYDROBROMIDEANDA  #079028","SUPPL-11","GALANTAMINE HYDROBROMIDE","WATSON LABS","Labeling","Approval"
"06/14/2022","GALANTAMINE HYDROBROMIDEANDA  #079028","SUPPL-13","GALANTAMINE HYDROBROMIDE","WATSON LABS","Labeling","Approval"
"06/14/2022","GALANTAMINE HYDROBROMIDEANDA  #079028","SUPPL-14","GALANTAMINE HYDROBROMIDE","WATSON LABS","Labeling","Approval"
"06/14/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090360","SUPPL-19","BUPRENORPHINE HYDROCHLORIDE","BARR","Labeling","Approval"
"06/14/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090819","SUPPL-23","BUPRENORPHINE HYDROCHLORIDE","ACTAVIS ELIZABETH","Labeling","Approval"
"06/14/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091422","SUPPL-37","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ACTAVIS ELIZABETH","Labeling","Approval"
"06/14/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091422","SUPPL-41","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ACTAVIS ELIZABETH","Labeling","Approval"
"06/14/2022","ONDANSETRON HYDROCHLORIDEANDA  #091483","SUPPL-11","ONDANSETRON HYDROCHLORIDE","AMNEAL PHARMS","Labeling","Approval"
"06/14/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #203136","SUPPL-35","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","AMNEAL PHARMS","Labeling","Approval"
"06/14/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #203326","SUPPL-21","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","HIKMA","Labeling","Approval"
"06/14/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #206953","SUPPL-7","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","DR REDDYS LABS SA","Labeling","Approval"
"06/14/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207000","SUPPL-16","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","SPECGX LLC","Labeling","Approval"
"06/14/2022","CANAGLIFLOZINANDA  #210451","ORIG-1","CANAGLIFLOZIN","TEVA PHARMS USA","","Tentative Approval"
"06/14/2022","BUPROPION HYDROCHLORIDEANDA  #211020","SUPPL-9","BUPROPION HYDROCHLORIDE","GRAVITI PHARMS","Labeling","Approval"
"06/14/2022","BUPROPION HYDROCHLORIDEANDA  #211020","SUPPL-12","BUPROPION HYDROCHLORIDE","GRAVITI PHARMS","Labeling","Approval"
"06/14/2022","ENOXAPARIN SODIUMANDA  #214856","ORIG-1","ENOXAPARIN SODIUM","NANJING KING-FRIEND","","Approval"
"06/14/2022","OBETICHOLIC ACIDANDA  #214862","ORIG-1","OBETICHOLIC ACID","APOTEX INC","","Tentative Approval"
"06/14/2022","BRIVARACETAMANDA  #214924","ORIG-1","BRIVARACETAM","MSN LABORATORIES PRIVATE LTD","","Tentative Approval"
"06/14/2022","CLORAZEPATE DIPOTASSIUMANDA  #215566","ORIG-1","CLORAZEPATE DIPOTASSIUM","COREPHARMA","","Approval"
"06/14/2022","SILIQBLA   #761032","SUPPL-10","BRODALUMAB","VALEANT LUXEMBOURG","","Approval"
"06/15/2022","NAROPINNDA   #020533","SUPPL-38","ROPIVACAINE HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"06/15/2022","EXEMESTANEANDA  #077431","SUPPL-10","EXEMESTANE","HIKMA","Labeling","Approval"
"06/15/2022","LAMOTRIGINEANDA  #078134","SUPPL-10","LAMOTRIGINE","HIKMA PHARMS","Labeling","Approval"
"06/15/2022","LAMOTRIGINEANDA  #078134","SUPPL-11","LAMOTRIGINE","HIKMA PHARMS","Labeling","Approval"
"06/15/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #201633","SUPPL-22","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"06/15/2022","VORICONAZOLEANDA  #205034","SUPPL-3","VORICONAZOLE","AMNEAL PHARMS","Labeling","Approval"
"06/15/2022","VORICONAZOLEANDA  #205034","SUPPL-5","VORICONAZOLE","AMNEAL PHARMS","Labeling","Approval"
"06/15/2022","VORICONAZOLEANDA  #205034","SUPPL-6","VORICONAZOLE","AMNEAL PHARMS","Labeling","Approval"
"06/15/2022","VORICONAZOLEANDA  #205034","SUPPL-7","VORICONAZOLE","AMNEAL PHARMS","Labeling","Approval"
"06/15/2022","VORICONAZOLEANDA  #205034","SUPPL-10","VORICONAZOLE","AMNEAL PHARMS","Labeling","Approval"
"06/15/2022","VORICONAZOLEANDA  #205034","SUPPL-11","VORICONAZOLE","AMNEAL PHARMS","Labeling","Approval"
"06/15/2022","VORICONAZOLEANDA  #205034","SUPPL-12","VORICONAZOLE","AMNEAL PHARMS","Labeling","Approval"
"06/15/2022","VORICONAZOLEANDA  #205034","SUPPL-13","VORICONAZOLE","AMNEAL PHARMS","Labeling","Approval"
"06/15/2022","SAXENDANDA   #206321","SUPPL-15","LIRAGLUTIDE RECOMBINANT","NOVO","Labeling","Approval"
"06/15/2022","VENCLEXTANDA   #208573","SUPPL-27","VENETOCLAX","ABBVIE","Labeling","Approval"
"06/15/2022","EXEMESTANEANDA  #210323","SUPPL-5","EXEMESTANE","CIPLA","Labeling","Approval"
"06/15/2022","BUPROPION HYDROCHLORIDEANDA  #211020","SUPPL-11","BUPROPION HYDROCHLORIDE","GRAVITI PHARMS","Manufacturing (CMC)","Approval"
"06/15/2022","EXEMESTANEANDA  #211031","SUPPL-3","EXEMESTANE","BRECKENRIDGE","Labeling","Approval"
"06/15/2022","FINTEPLANDA   #212102","SUPPL-5","FENFLURAMINE HYDROCHLORIDE","ZOGENIX INC","Labeling","Approval"
"06/15/2022","VERAPAMIL HYDROCHLORIDEANDA  #214653","ORIG-1","VERAPAMIL HYDROCHLORIDE","MANKIND PHARMA","","Approval"
"06/15/2022","BREXAFEMMENDA   #214900","SUPPL-1","IBREXAFUNGERP CITRATE","SCYNEXIS","Labeling","Approval"
"06/15/2022","SOLIFENACIN SUCCINATEANDA  #215761","ORIG-1","SOLIFENACIN SUCCINATE","ANNORA PHARMA","","Approval"
"06/16/2022","FERAHEMENDA   #022180","SUPPL-25","FERUMOXYTOL","COVIS","Labeling","Approval"
"06/16/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090622","SUPPL-33","BUPRENORPHINE HYDROCHLORIDE","ETHYPHARM","Labeling","Approval"
"06/16/2022","POLYETHYLENE GLYCOL 3350ANDA  #090685","SUPPL-14","POLYETHYLENE GLYCOL 3350","PERRIGO R AND D","Manufacturing (CMC)","Approval"
"06/16/2022","DEXLANSOPRAZOLEANDA  #202294","SUPPL-6","DEXLANSOPRAZOLE","PAR PHARM INC","Manufacturing (CMC)","Approval"
"06/16/2022","JUXTAPIDNDA   #203858","SUPPL-24","LOMITAPIDE MESYLATE","AMRYT","REMS","Approval"
"06/16/2022","QUETIAPINE FUMARATEANDA  #204316","ORIG-1","QUETIAPINE FUMARATE","HETERO LABS LTD V","","Approval"
"06/16/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #204431","SUPPL-22","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ETHYPHARM USA CORP","Labeling","Approval"
"06/16/2022","FLUNISOLIDEANDA  #207802","ORIG-1","FLUNISOLIDE","RICONPHARMA LLC","","Approval"
"06/16/2022","LINACLOTIDEANDA  #211255","ORIG-1","LINACLOTIDE","ACTAVIS LABS FL INC","","Tentative Approval"
"06/16/2022","ZULRESSONDA   #211371","SUPPL-7","BREXANOLONE","SAGE THERAP","Efficacy","Approval"
"06/16/2022","GALLIUM GA 68 GOZETOTIDENDA   #212642","SUPPL-2","GALLIUM GA-68 GOZETOTIDE","UNIV CA LOS ANGELES","Labeling","Approval"
"06/16/2022","GALLIUM GA 68 GOZETOTIDENDA   #212643","SUPPL-2","GALLIUM GA-68 GOZETOTIDE","UNIV OF CA SAN FRAN","Labeling","Approval"
"06/16/2022","CLORAZEPATE DIPOTASSIUMANDA  #213730","ORIG-1","CLORAZEPATE DIPOTASSIUM","NOVITIUM PHARMA","","Approval"
"06/16/2022","IMCIVREENDA   #213793","SUPPL-1","SETMELANOTIDE ACETATE","RHYTHM","Efficacy","Approval"
"06/16/2022","SKYRIZIBLA   #761105","SUPPL-16","RISANKIZUMAB-RZAA","ABBVIE INC","","Approval"
"06/16/2022","SKYRIZIBLA   #761262","ORIG-1","RISANKIZUMAB-RZAA","ABBVIE INC","","Approval"
"06/17/2022","BUPRENEXNDA   #018401","SUPPL-26","BUPRENORPHINE HYDROCHLORIDE","INDIVIOR INC","Labeling","Approval"
"06/17/2022","SUBUTEXNDA   #020732","SUPPL-27","BUPRENORPHINE HYDROCHLORIDE","INDIVIOR INC","Labeling","Approval"
"06/17/2022","SUBUTEXNDA   #020732","SUPPL-28","BUPRENORPHINE HYDROCHLORIDE","INDIVIOR INC","Labeling","Approval"
"06/17/2022","SUBOXONENDA   #020733","SUPPL-31","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","INDIVIOR INC","Labeling","Approval"
"06/17/2022","SUBOXONENDA   #020733","SUPPL-32","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","INDIVIOR INC","Labeling","Approval"
"06/17/2022","BUTRANSNDA   #021306","SUPPL-39","BUPRENORPHINE","PURDUE PHARMA LP","Labeling","Approval"
"06/17/2022","SUBOXONENDA   #022410","SUPPL-46","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","INDIVIOR INC","Labeling","Approval"
"06/17/2022","SUBOXONENDA   #022410","SUPPL-47","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","INDIVIOR INC","Labeling","Approval"
"06/17/2022","SUMATRIPTAN SUCCINATEANDA  #078327","SUPPL-16","SUMATRIPTAN SUCCINATE","AUROBINDO PHARMA","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #078633","SUPPL-26","BUPRENORPHINE HYDROCHLORIDE","HIKMA","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #078633","SUPPL-28","BUPRENORPHINE HYDROCHLORIDE","HIKMA","Labeling","Approval"
"06/17/2022","QUETIAPINE FUMARATEANDA  #078679","SUPPL-9","QUETIAPINE FUMARATE","SANDOZ","Labeling","Approval"
"06/17/2022","QUETIAPINE FUMARATEANDA  #078679","SUPPL-10","QUETIAPINE FUMARATE","SANDOZ","Labeling","Approval"
"06/17/2022","QUETIAPINE FUMARATEANDA  #078679","SUPPL-13","QUETIAPINE FUMARATE","SANDOZ","Labeling","Approval"
"06/17/2022","QUETIAPINE FUMARATEANDA  #078679","SUPPL-14","QUETIAPINE FUMARATE","SANDOZ","Labeling","Approval"
"06/17/2022","QUETIAPINE FUMARATEANDA  #078679","SUPPL-15","QUETIAPINE FUMARATE","SANDOZ","Labeling","Approval"
"06/17/2022","QUETIAPINE FUMARATEANDA  #078679","SUPPL-16","QUETIAPINE FUMARATE","SANDOZ","Labeling","Approval"
"06/17/2022","QUETIAPINE FUMARATEANDA  #078679","SUPPL-17","QUETIAPINE FUMARATE","SANDOZ","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090279","SUPPL-13","BUPRENORPHINE HYDROCHLORIDE","RUBICON","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090279","SUPPL-17","BUPRENORPHINE HYDROCHLORIDE","RUBICON","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090622","SUPPL-34","BUPRENORPHINE HYDROCHLORIDE","ETHYPHARM","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090622","SUPPL-36","BUPRENORPHINE HYDROCHLORIDE","ETHYPHARM","Labeling","Approval"
"06/17/2022","LEVETIRACETAMANDA  #090767","SUPPL-7","LEVETIRACETAM","VKT PHARMA","Labeling","Approval"
"06/17/2022","LEVETIRACETAMANDA  #090767","SUPPL-8","LEVETIRACETAM","VKT PHARMA","Labeling","Approval"
"06/17/2022","LEVETIRACETAMANDA  #090767","SUPPL-9","LEVETIRACETAM","VKT PHARMA","Labeling","Approval"
"06/17/2022","LEVETIRACETAMANDA  #090767","SUPPL-11","LEVETIRACETAM","VKT PHARMA","Labeling","Approval"
"06/17/2022","LEVETIRACETAMANDA  #090767","SUPPL-12","LEVETIRACETAM","VKT PHARMA","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090819","SUPPL-24","BUPRENORPHINE HYDROCHLORIDE","ACTAVIS ELIZABETH","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #090819","SUPPL-26","BUPRENORPHINE HYDROCHLORIDE","ACTAVIS ELIZABETH","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091149","SUPPL-18","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","TEVA PHARMS USA","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091149","SUPPL-20","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","TEVA PHARMS USA","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091422","SUPPL-43","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ACTAVIS ELIZABETH","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091422","SUPPL-45","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ACTAVIS ELIZABETH","Labeling","Approval"
"06/17/2022","ENBRELBLA   #103795","SUPPL-5590","ETANERCEPT","IMMUNEX","","Approval"
"06/17/2022","ENTYVIOBLA   #125476","SUPPL-46","VEDOLIZUMAB","TAKEDA PHARMS USA","","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #201066","SUPPL-16","BUPRENORPHINE HYDROCHLORIDE","MYLAN PHARMS","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #201066","SUPPL-18","BUPRENORPHINE HYDROCHLORIDE","MYLAN PHARMS","Labeling","Approval"
"06/17/2022","TINIDAZOLEANDA  #201172","SUPPL-3","TINIDAZOLE","HIKMA","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #201633","SUPPL-20","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #201633","SUPPL-24","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #201760","SUPPL-22","BUPRENORPHINE HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #201760","SUPPL-26","BUPRENORPHINE HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #203136","SUPPL-37","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","AMNEAL PHARMS","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #203136","SUPPL-40","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","AMNEAL PHARMS","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #203326","SUPPL-23","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","HIKMA","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #203326","SUPPL-25","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","HIKMA","Labeling","Approval"
"06/17/2022","ZUBSOLVNDA   #204242","SUPPL-21","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","OREXO US INC","Labeling","Approval"
"06/17/2022","ZUBSOLVNDA   #204242","SUPPL-23","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","OREXO US INC","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #204431","SUPPL-24","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ETHYPHARM USA CORP","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #204431","SUPPL-26","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ETHYPHARM USA CORP","Labeling","Approval"
"06/17/2022","PROBUPHINENDA   #204442","SUPPL-12","BUPRENORPHINE HYDROCHLORIDE","TITAN PHARMS","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205022","SUPPL-12","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","LANNETT CO INC","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205022","SUPPL-14","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","LANNETT CO INC","Labeling","Approval"
"06/17/2022","TRANEXAMIC ACIDANDA  #205228","SUPPL-3","TRANEXAMIC ACID","ZYDUS PHARMS","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205601","SUPPL-7","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RHODES PHARMS","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205601","SUPPL-11","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RHODES PHARMS","Labeling","Approval"
"06/17/2022","BUNAVAILNDA   #205637","SUPPL-23","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","BDSI","Labeling","Approval"
"06/17/2022","BUNAVAILNDA   #205637","SUPPL-24","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","BDSI","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #206953","SUPPL-8","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","DR REDDYS LABS SA","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #206953","SUPPL-10","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","DR REDDYS LABS SA","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207000","SUPPL-21","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","SPECGX LLC","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207000","SUPPL-24","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","SPECGX LLC","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #207276","SUPPL-11","BUPRENORPHINE HYDROCHLORIDE","RHODES PHARMS","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDEANDA  #207276","SUPPL-13","BUPRENORPHINE HYDROCHLORIDE","RHODES PHARMS","Labeling","Approval"
"06/17/2022","BELBUCANDA   #207932","SUPPL-19","BUPRENORPHINE HYDROCHLORIDE","BDSI","Labeling","Approval"
"06/17/2022","BELBUCANDA   #207932","SUPPL-20","BUPRENORPHINE HYDROCHLORIDE","BDSI","Labeling","Approval"
"06/17/2022","CASSIPANDA   #208042","SUPPL-5","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","TEVA PHARMS USA","Labeling","Approval"
"06/17/2022","CASSIPANDA   #208042","SUPPL-7","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","TEVA PHARMS USA","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #209069","SUPPL-5","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","WES PHARMA INC","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #209069","SUPPL-8","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","WES PHARMA INC","Labeling","Approval"
"06/17/2022","SUBLOCADENDA   #209819","SUPPL-20","BUPRENORPHINE","INDIVIOR INC","Labeling","Approval"
"06/17/2022","APIXABANANDA  #209898","SUPPL-1","APIXABAN","INDOCO","Labeling","Approval"
"06/17/2022","APIXABANANDA  #209898","SUPPL-2","APIXABAN","INDOCO","Labeling","Approval"
"06/17/2022","TEGSEDINDA   #211172","SUPPL-10","INOTERSEN SODIUM","AKCEA THERAPS","Labeling","Approval"
"06/17/2022","TADLIQNDA   #214522","ORIG-1","TADALAFIL","CMP DEV LLC","Type 5 - New Formulation or New Manufacturer","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #214930","SUPPL-1","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ALKEM LABS LTD","Labeling","Approval"
"06/17/2022","BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #214930","SUPPL-4","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ALKEM LABS LTD","Labeling","Approval"
"06/17/2022","OBETICHOLIC ACIDANDA  #214935","ORIG-1","OBETICHOLIC ACID","OPTIMUS PHARMA PRIVATE LTD","","Tentative Approval"
"06/17/2022","PHEBURANENDA   #216513","ORIG-1","SODIUM PHENYLBUTYRATE","MEDUNIK","Type 5 - New Formulation or New Manufacturer","Approval"
"06/17/2022","HADLIMABLA   #761059","SUPPL-4","ADALIMUMAB-BWWD","SAMSUNG BIOEPIS CO LTD","","Approval"
"06/21/2022","JANUVIANDA   #021995","SUPPL-50","SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Labeling","Approval"
"06/21/2022","JANUMETNDA   #022044","SUPPL-52","METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","MSD SUB MERCK","Labeling","Approval"
"06/21/2022","KEYTRUDABLA   #125514","SUPPL-131","PEMBROLIZUMAB","MERCK SHARP DOHME","","Approval"
"06/21/2022","JANUMET XRNDA   #202270","SUPPL-26","METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Labeling","Approval"
"06/21/2022","STEGLUJANNDA   #209805","SUPPL-11","ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE","MSD SUB MERCK","Labeling","Approval"
"06/21/2022","MAYZENTNDA   #209884","SUPPL-11","SIPONIMOD FUMARIC ACID","NOVARTIS","Labeling","Approval"
"06/21/2022","CARMUSTINEANDA  #211011","ORIG-1","CARMUSTINE","INGENUS PHARMS LLC","","Approval"
"06/21/2022","NALOXONE HYDROCHLORIDEANDA  #211951","ORIG-1","NALOXONE HYDROCHLORIDE","PADAGIS ISRAEL","","Approval"
"06/21/2022","IMATINIB MESYLATEANDA  #212135","ORIG-1","IMATINIB MESYLATE","QILU PHARM HAINAN","","Approval"
"06/21/2022","APIXABANANDA  #213903","ORIG-1","APIXABAN","ZHEJIANG YONGNING PHARMACEUTICAL CO LTD","","Tentative Approval"
"06/22/2022","APOKYNNDA   #021264","SUPPL-21","APOMORPHINE HYDROCHLORIDE","MDD US","Labeling","Approval"
"06/22/2022","TIROSINTNDA   #021924","SUPPL-21","LEVOTHYROXINE SODIUM","INSTITUT BIOCHIMIQUE","Manufacturing (CMC)","Approval"
"06/22/2022","DOXYCYCLINEANDA  #065356","SUPPL-11","DOXYCYCLINE","SUN PHARM INDS LTD","Labeling","Approval"
"06/22/2022","DOXYCYCLINEANDA  #065356","SUPPL-13","DOXYCYCLINE","SUN PHARM INDS LTD","Labeling","Approval"
"06/22/2022","DOXYCYCLINEANDA  #065356","SUPPL-15","DOXYCYCLINE","SUN PHARM INDS LTD","Labeling","Approval"
"06/22/2022","SUMATRIPTAN SUCCINATEANDA  #078327","SUPPL-17","SUMATRIPTAN SUCCINATE","AUROBINDO PHARMA","Manufacturing (CMC)","Approval"
"06/22/2022","TAFINLARNDA   #202806","SUPPL-22","DABRAFENIB MESYLATE","NOVARTIS","Efficacy","Approval"
"06/22/2022","MEKINISTNDA   #204114","SUPPL-24","TRAMETINIB DIMETHYL SULFOXIDE","NOVARTIS","Efficacy","Approval"
"06/22/2022","ADAPALENE AND BENZOYL PEROXIDEANDA  #209641","ORIG-1","ADAPALENE; BENZOYL PEROXIDE","ACTAVIS LABS UT INC","","Approval"
"06/22/2022","VIGABATRINANDA  #210042","ORIG-1","VIGABATRIN","AMNEAL PHARMS","","Approval"
"06/22/2022","PIPERACILLIN AND TAZOBACTAMANDA  #212287","SUPPL-6","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","ASTRAL","Labeling","Approval"
"06/22/2022","CARGLUMIC ACIDANDA  #213395","ORIG-1","CARGLUMIC ACID","NAVINTA LLC","","Approval"
"06/22/2022","CARGLUMIC ACIDANDA  #213729","SUPPL-1","CARGLUMIC ACID","NOVITIUM PHARMA","Manufacturing (CMC)","Approval"
"06/22/2022","PEMETREXED DISODIUMNDA   #214218","ORIG-1","PEMETREXED DISODIUM","HOSPIRA","Type 5 - New Formulation or New Manufacturer","Approval"
"06/22/2022","ERLOTINIB HYDROCHLORIDEANDA  #216342","ORIG-1","ERLOTINIB HYDROCHLORIDE","EUGIA PHARMA","","Approval"
"06/23/2022","PREVACID 24 HRNDA   #022327","SUPPL-30","LANSOPRAZOLE","PERRIGO PHARMA INTL","Labeling","Approval"
"06/23/2022","ONDANSETRON HYDROCHLORIDEANDA  #076960","SUPPL-8","ONDANSETRON HYDROCHLORIDE","HIKMA","Labeling","Approval"
"06/23/2022","ONDANSETRON HYDROCHLORIDEANDA  #076960","SUPPL-9","ONDANSETRON HYDROCHLORIDE","HIKMA","Labeling","Approval"
"06/23/2022","LAMOTRIGINEANDA  #078443","SUPPL-2","LAMOTRIGINE","MYLAN LABS LTD","Labeling","Approval"
"06/23/2022","ONDANSETRON HYDROCHLORIDEANDA  #078776","SUPPL-14","ONDANSETRON HYDROCHLORIDE","AUROBINDO PHARMA","Labeling","Approval"
"06/23/2022","ONDANSETRON HYDROCHLORIDEANDA  #078776","SUPPL-15","ONDANSETRON HYDROCHLORIDE","AUROBINDO PHARMA","Labeling","Approval"
"06/23/2022","ONDANSETRON HYDROCHLORIDEANDA  #091342","SUPPL-8","ONDANSETRON HYDROCHLORIDE","LANNETT CO INC","Labeling","Approval"
"06/23/2022","TRANEXAMIC ACIDANDA  #091657","SUPPL-10","TRANEXAMIC ACID","MYLAN INSTITUTIONAL","Labeling","Approval"
"06/23/2022","URSODIOLANDA  #200826","SUPPL-9","URSODIOL","IMPAX LABS INC","Labeling","Approval"
"06/23/2022","CABAZITAXELANDA  #207619","ORIG-1","CABAZITAXEL","BRECKENRIDGE","","Approval"
"06/23/2022","BUPROPION HYDROCHLORIDEANDA  #211347","SUPPL-9","BUPROPION HYDROCHLORIDE","YICHANG HUMANWELL","Labeling","Approval"
"06/23/2022","RELEXXIINDA   #216117","ORIG-1","METHYLPHENIDATE HYDROCHLORIDE","OSMOTICA PHARM US","Type 5 - New Formulation or New Manufacturer","Approval"
"06/23/2022","TRIENTINE HYDROCHLORIDEANDA  #216356","ORIG-1","TRIENTINE HYDROCHLORIDE","HETERO LABS LTD III","","Approval"
"06/24/2022","NITROMISTNDA   #021780","SUPPL-8","NITROGLYCERIN","EVUS","Labeling","Approval"
"06/24/2022","QSYMIANDA   #022580","SUPPL-21","PHENTERMINE HYDROCHLORIDE; TOPIRAMATE","VIVUS","Efficacy","Approval"
"06/24/2022","AMOXICILLINANDA  #207471","ORIG-1","AMOXICILLIN","MICRO LABS","","Approval"
"06/24/2022","ABIRATERONE ACETATEANDA  #212206","ORIG-1","ABIRATERONE ACETATE","TEVA PHARMS USA","","Approval"
"06/24/2022","TIMOLOL MALEATEANDA  #214645","ORIG-1","TIMOLOL MALEATE","GLAND PHARMA LTD","","Approval"
"06/24/2022","VEKLURYNDA   #214787","SUPPL-15","REMDESIVIR","GILEAD SCIENCES INC","Labeling","Approval"
"06/24/2022","VIGABATRINANDA  #214961","ORIG-1","VIGABATRIN","PYROS PHARMS","","Approval"
"06/24/2022","DOXEPIN HYDROCHLORIDEANDA  #215113","ORIG-1","DOXEPIN HYDROCHLORIDE","MSN","","Approval"
"06/24/2022","ESOMEPRAZOLE MAGNESIUMANDA  #216349","ORIG-1","ESOMEPRAZOLE MAGNESIUM","GRAVITI PHARMS","","Approval"
"06/27/2022","HUMULIN RBLA   #018780","SUPPL-180","INSULIN HUMAN","LILLY","","Approval"
"06/27/2022","HUMULIN RBLA   #018780","SUPPL-180","INSULIN RECOMBINANT HUMAN","LILLY","","Approval"
"06/27/2022","HUMULIN R KWIKPENBLA   #018780","SUPPL-180","INSULIN HUMAN","LILLY","","Approval"
"06/27/2022","HUMULIN R PENBLA   #018780","SUPPL-180","INSULIN RECOMBINANT HUMAN","LILLY","","Approval"
"06/27/2022","HUMULIN NBLA   #018781","SUPPL-193","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","","Approval"
"06/27/2022","HUMULIN 70/30BLA   #019717","SUPPL-174","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","","Approval"
"06/27/2022","HUMULIN 70/30 PENBLA   #019717","SUPPL-174","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","","Approval"
"06/27/2022","LUBIPROSTONEANDA  #201442","ORIG-1","LUBIPROSTONE","ANCHEN PHARMS","","Approval"
"06/27/2022","OLMESARTAN MEDOXOMILANDA  #203012","SUPPL-6","OLMESARTAN MEDOXOMIL","ALEMBIC","Labeling","Approval"
"06/27/2022","VALGANCICLOVIR HYDROCHLORIDEANDA  #204750","SUPPL-8","VALGANCICLOVIR HYDROCHLORIDE","AUROBINDO PHARMA LTD","Labeling","Approval"
"06/27/2022","VALGANCICLOVIR HYDROCHLORIDEANDA  #204750","SUPPL-10","VALGANCICLOVIR HYDROCHLORIDE","AUROBINDO PHARMA LTD","Labeling","Approval"
"06/27/2022","RIVAROXABANANDA  #212220","ORIG-1","RIVAROXABAN","MYLAN PHARMS INC","","Tentative Approval"
"06/27/2022","XCOPRINDA   #212839","SUPPL-6","CENOBAMATE","SK LIFE","Labeling","Approval"
"06/27/2022","XCOPRINDA   #212839","SUPPL-7","CENOBAMATE","SK LIFE","Labeling","Approval"
"06/27/2022","TRANYLCYPROMINE SULFATEANDA  #213503","ORIG-1","TRANYLCYPROMINE SULFATE","CROSSMEDIKA SA","","Approval"
"06/27/2022","DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUMANDA  #214201","ORIG-1","DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM","GUARDIAN DRUG","","Approval"
"06/28/2022","NAROPINNDA   #020533","SUPPL-44","ROPIVACAINE HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"06/28/2022","NASONEXNDA   #020762","SUPPL-56","MOMETASONE FUROATE","ORGANON LLC","Labeling","Approval"
"06/28/2022","KABIVEN IN PLASTIC CONTAINERNDA   #200656","SUPPL-14","AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL","FRESENIUS KABI USA","Labeling","Approval"
"06/28/2022","PERIKABIVEN IN PLASTIC CONTAINERNDA   #200656","SUPPL-14","AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL","FRESENIUS KABI USA","Labeling","Approval"
"06/28/2022","TRAMADOL HYDROCHLORIDEANDA  #202075","SUPPL-4","TRAMADOL HYDROCHLORIDE","ACI","Labeling","Approval"
"06/28/2022","CISATRACURIUM BESYLATEANDA  #203078","ORIG-1","CISATRACURIUM BESYLATE","HIKMA","","Approval"
"06/28/2022","OLMESARTAN MEDOXOMILANDA  #204798","SUPPL-6","OLMESARTAN MEDOXOMIL","AUROBINDO PHARMA","Labeling","Approval"
"06/28/2022","DILTIAZEM HYDROCHLORIDEANDA  #211596","SUPPL-1","DILTIAZEM HYDROCHLORIDE","EDENBRIDGE PHARMS","Manufacturing (CMC)","Approval"
"06/28/2022","PRIMIDONEANDA  #214896","ORIG-1","PRIMIDONE","RUBICON","","Approval"
"06/28/2022","BUPROPION HYDROCHLORIDEANDA  #215568","SUPPL-2","BUPROPION HYDROCHLORIDE","GRANULES","Labeling","Approval"
"06/29/2022","HALOPERIDOLANDA  #070278","SUPPL-38","HALOPERIDOL","MYLAN","Manufacturing (CMC)","Approval"
"06/29/2022","PALIPERIDONEANDA  #208643","ORIG-1","PALIPERIDONE","LUPIN LTD","","Approval"
"06/29/2022","LACOSAMIDEANDA  #209465","ORIG-1","LACOSAMIDE","ZYDUS PHARMS","","Approval"
"06/29/2022","ORTIKOSNDA   #211929","SUPPL-8","BUDESONIDE","SUN PHARM INDS INC","Labeling","Approval"
"06/29/2022","ENALAPRIL MALEATEANDA  #212894","ORIG-1","ENALAPRIL MALEATE","AMNEAL","","Approval"
"06/29/2022","VALGANCICLOVIR HYDROCHLORIDEANDA  #213306","SUPPL-1","VALGANCICLOVIR HYDROCHLORIDE","GRANULES","Labeling","Approval"
"06/29/2022","VALGANCICLOVIR HYDROCHLORIDEANDA  #213306","SUPPL-3","VALGANCICLOVIR HYDROCHLORIDE","GRANULES","Labeling","Approval"
"06/29/2022","MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5ANDA  #215370","ORIG-1","MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE","FRESENIUS KABI USA","","Approval"
"06/29/2022","VENLAFAXINE BESYLATENDA   #215429","ORIG-1","VENLAFAXINE BESYLATE","ALMATICA","Type 2 - New Active Ingredient and Type 3 - New Dosage Form","Approval"
"06/29/2022","VENLAFAXINE BESYLATENDA   #215429","ORIG-2","VENLAFAXINE BESYLATE","ALMATICA","Type 2 - New Active Ingredient and Type 3 - New Dosage Form","Approval"
"06/29/2022","DROSPIRENONENDA   #216285","ORIG-1","DROSPIRENONE","EXELTIS USA INC","Type 3 - New Dosage Form","Approval"
"06/30/2022","AUGMENTIN ES-600NDA   #050755","SUPPL-24","AMOXICILLIN; CLAVULANATE POTASSIUM","US ANTIBIOTICS","Labeling","Approval"
"06/30/2022","LOSARTAN POTASSIUMANDA  #076958","SUPPL-17","LOSARTAN POTASSIUM","TEVA","Labeling","Approval"
"06/30/2022","RAMIPRILANDA  #077626","SUPPL-25","RAMIPRIL","LUPIN","Labeling","Approval"
"06/30/2022","RAMIPRILANDA  #078832","SUPPL-17","RAMIPRIL","ZYDUS PHARMS USA","Labeling","Approval"
"06/30/2022","LAMOTRIGINEANDA  #078947","SUPPL-37","LAMOTRIGINE","TORRENT PHARMS","Labeling","Approval"
"06/30/2022","LAMOTRIGINEANDA  #078947","SUPPL-38","LAMOTRIGINE","TORRENT PHARMS","Labeling","Approval"
"06/30/2022","RAMELTEONANDA  #091693","SUPPL-3","RAMELTEON","DR REDDYS LABS SA","Labeling","Approval"
"06/30/2022","KYPROLISNDA   #202714","SUPPL-34","CARFILZOMIB","ONYX THERAP","Efficacy","Approval"
"06/30/2022","LENALIDOMIDEANDA  #209348","SUPPL-1","LENALIDOMIDE","DR REDDYS","REMS","Approval"
"06/30/2022","EMPAGLIFLOZINANDA  #212421","ORIG-1","EMPAGLIFLOZIN","LAURUS GENERICS INC","","Tentative Approval"
"06/30/2022","DHIVYNDA   #214869","SUPPL-2","CARBIDOPA; LEVODOPA","AVION PHARMS","Labeling","Approval"